Rekah Pharmaceutical Industry Ltd (REKA) — Defensive Interval Ratio
Rekah Pharmaceutical Industry Ltd (REKA) has a Defensive Interval Ratio of 326 days as of December 2025. Defensive assets of ILA135.44 Million (cash ILA-, short-term investments ILA39.00K, receivables ILA135.40 Million) cover 326 days of daily cash needs of ILA416.07K/day. Check Rekah Pharmaceutical Industry Ltd (REKA) tangible net worth to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Rekah Pharmaceutical Industry Ltd Defensive Interval Ratio (2004–2025)
This chart shows how Rekah Pharmaceutical Industry Ltd's Defensive Interval Ratio has evolved across 22 annual periods from 2004 to 2025. As of December 2025, the ratio stands at 326 days, meaning defensive assets of ILA135.44 Million can fund 326 days of operations without new revenue. Also explore REKA shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Rekah Pharmaceutical Industry Ltd (2004–2025)
The table below presents the year-by-year Defensive Interval Ratio for Rekah Pharmaceutical Industry Ltd from 2004 to 2025, covering 22 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Rekah Pharmaceutical Industry Ltd stock valuation.
| Year | DIR (days) | Defensive Assets (ILA) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 326 days | ILA135.44 Million | ILA416.07K/day | ILA- | ILA39.00K | ▲ +27 days |
| 2024 | 299 days | ILA129.39 Million | ILA432.99K/day | ILA- | ILA39.00K | ▲ +0 days |
| 2023 | 299 days | ILA117.72 Million | ILA393.93K/day | ILA- | ILA39.00K | ▼ -18 days |
| 2022 | 317 days | ILA120.79 Million | ILA380.90K/day | ILA- | ILA80.00K | ▼ -80 days |
| 2021 | 398 days | ILA107.41 Million | ILA270.17K/day | ILA- | ILA39.00K | ▲ +102 days |
| 2020 | 296 days | ILA87.67 Million | ILA296.60K/day | ILA- | ILA40.00K | ▼ -42 days |
| 2019 | 338 days | ILA78.32 Million | ILA232.01K/day | ILA- | ILA40.00K | ▼ -5 days |
| 2018 | 342 days | ILA74.84 Million | ILA218.76K/day | ILA- | ILA43.00K | ▼ -53 days |
| 2017 | 396 days | ILA84.49 Million | ILA213.61K/day | ILA- | ILA29.00K | ▲ +28 days |
| 2016 | 367 days | ILA93.68 Million | ILA255.18K/day | ILA- | ILA1.78 Million | ▼ -51 days |
| 2015 | 418 days | ILA105.97 Million | ILA253.28K/day | ILA- | ILA1.75 Million | ▲ +124 days |
| 2014 | 295 days | ILA106.29 Million | ILA360.78K/day | ILA- | ILA4.30 Million | ▲ +118 days |
| 2013 | 177 days | ILA97.74 Million | ILA552.54K/day | ILA- | ILA5.22 Million | ▼ -6 days |
| 2012 | 183 days | ILA98.47 Million | ILA538.87K/day | ILA- | ILA3.38 Million | ▼ -28 days |
| 2011 | 211 days | ILA97.05 Million | ILA460.67K/day | ILA- | ILA9.22 Million | ▼ -37 days |
| 2010 | 247 days | ILA103.99 Million | ILA420.26K/day | ILA- | ILA18.76 Million | ▼ -46 days |
| 2009 | 294 days | ILA107.22 Million | ILA364.86K/day | ILA- | ILA24.34 Million | ▼ -71 days |
| 2008 | 365 days | ILA114.02 Million | ILA312.77K/day | ILA- | ILA26.70 Million | ▼ -13 days |
| 2007 | 377 days | ILA124.29 Million | ILA329.34K/day | ILA- | ILA35.68 Million | ▲ +28 days |
| 2006 | 350 days | ILA117.66 Million | ILA336.35K/day | ILA- | ILA32.45 Million | ▼ -51 days |
| 2005 | 401 days | ILA106.19 Million | ILA265.08K/day | ILA- | ILA37.18 Million | ▲ +150 days |
| 2004 | 250 days | ILA65.78 Million | ILA262.99K/day | ILA- | ILA- | — |